219
Views
10
CrossRef citations to date
0
Altmetric
Original Article

A comparison of six major platelet functional tests to assess the impact of carbon nanomaterials on platelet function: A practical guide

, , , , , , , , & show all
Pages 220-232 | Received 19 Oct 2012, Accepted 06 Mar 2013, Published online: 15 Apr 2013

References

  • Bakry R, Vallant RM, Najam-ul-Haq M, Rainer M, Szabo Z, Huck CW, et al. 2007. Medicinal applications of fullerenes. Int J Nanomedicine 2:639–649.
  • Barlow PG, Donaldson K, MacCallum J, Clouter A, Stone V. 2005. Serum exposed to nanoparticle carbon black displays increased potential to induce macrophage migration. Toxicol Lett 155:397–401.
  • Bihari P, Holzer M, Praetner M, Fent J, Lerchenberger M, Reichel CA, et al. 2010. Single-walled carbon nanotubes activate platelets and accelerate thrombus formation in the microcirculation. Toxicology 269:148–154.
  • Burke AR, Singh RN, Carroll DL, Owen JD, Kock ND, D'Agostino R Jr, et al. 2011. Determinants of the thrombogenic potential of multiwalled carbon nanotubes. Biomaterials 32:5970–5978.
  • Dobrovolskaia MA, Aggarwal P, Hall JB, McNeil SE. 2008a. Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution. Mol Pharm 5:487–495.
  • Dobrovolskaia MA, Clogston JD, Neun BW, Hall JB, Patri AK, McNeil SE. 2008b. Method for analysis of nanoparticle hemolytic properties in vitro. Nano Lett 8:2180–2187.
  • Donaldson K, Brown D, Clouter A, Duffin R, MacNee W, Renwick L, et al. 2002. The pulmonary toxicology of ultrafine particles. J Aerosol Med 15:213–220.
  • Favaloro EJ. 2009. Internal quality control and external quality assurance of platelet function tests. Semin Thromb Hemost 35:139–149.
  • Favaloro EJ, Lippi G, Franchini M. 2010. Contemporary platelet function testing. Clin Chem Lab Med 48:579–598.
  • Ferraz N, Carlsson J, Hong J, Ott MK. 2008. Influence of nanoporesize on platelet adhesion and activation. J Mater Sci Mater Med 19:3115–3121.
  • Geys J, Nemmar A, Verbeken E, Smolders E, Ratoi M, Hoylaerts MF, et al. 2008. Acute toxicity and prothrombotic effects of quantum dots: impact of surface charge. Environ Health Perspect 116:1607–1613.
  • Gouya G, Jilma B, Niel M, Eichelberger B, Wolzt M, Panzer S. 2009. Cross validation of aspirin effect in healthy individuals by Impact-R and PFA-100: a double blind randomized placebo controlled trial. Platelets 20:171–176.
  • Harrison P, Mumford A. 2009. Screening tests of platelet function: update on their appropriate uses for diagnostic testing. Semin Thromb Hemost 35:150–157.
  • Hulstein JJ, Lenting PJ, de Laat B, Derksen RH, Fijnheer R, de Groot PG. 2007. beta2-Glycoprotein I inhibits von Willebrand factor dependent platelet adhesion and aggregation. Blood 110:1483–1491.
  • Jiang J, Oberdörster G, Biswas P. 2009. Characterization of size, surface charge, and agglomeration state of nanoparticle dispersions for toxicological studies. J Nanopart Res 11:77–89.
  • Jun EA, Lim KM, Kim K, Bae ON, Noh JY, Chung KH, et al. 2011. Silver nanoparticles enhance thrombus formation through increased platelet aggregation and procoagulant activity. Nanotoxicology 5(2):157–167.
  • Karagkiozaki VC, Logothetidis SD, Kassavetis SN, Giannoglou GD. 2010. Nanomedicine for the reduction of the thrombogenicity of stent coatings. Int J Nanomedicine 5:239–248.
  • Kundu SK, Heilmann EJ, Sio R, Garcia C, Davidson RM, Ostgaard RA. 1995. Description of an in vitro platelet function analyzer–PFA-100. Semin Thromb Hemost 21(Suppl 2):106–112.
  • Lacerda SH, Semberova J, Holada K, Simakova O, Hudson SD, Simak J. 2010. Carbon nanotubes activate store-operated calcium entry in human blood platelets. ACS Nano 5:5808–5813.
  • Mayer A, Vadon M, Rinner B, Novak A, Wintersteiger R, Frohlich E. 2009. The role of nanoparticle size in hemocompatibility. Toxicology 258:139–147.
  • Mejia J, Tichelaar F, Saout C, Toussaint O, Masereel B, Mekhalif Z, et al. 2011. Effects of the dispersion methods in Pluronic F108 on the size and the surface composition of MWCNTs and their implications in toxicology assessment. J Nanopart Res 13:655–667.
  • Mengistu AM, Mayer J, Boldt J, Rohm KD. 2009. Whole-blood aggregometry: are there any limits with regard to platelet counts? Acta Anaesthesiol Scand 53:72–76.
  • Michelson AD, Linden MD, Furman MI, Li Y, Barnard MR, Fox ML, et al. 2007. Evidence that pre-existent variability in platelet response to ADP accounts for 'clopidogrel resistance'. J Thromb Haemost 5:75–81.
  • Miller G, Senjen R. 2008. Out of the laboratory and on to our plates. Nanotechnology in food & agriculture. Friends Earth 1–63.
  • Moghimi SM, Hunter AC, Murray JC. 2005. Nanomedicine: current status and future prospects. FASEB J 19:311–330.
  • Morel-Kopp MC, Aboud M, Tan CW, Kulathilake C, Ward C. 2010. Whole blood impedance aggregometry detects heparin-induced thrombocytopenia antibodies. Thromb Res 125:e234–e239.
  • Nel AE, Madler L, Velegol D, Xia T, Hoek EM, Somasundaran P, et al. 2009. Understanding biophysicochemical interactions at the nano-bio interface. Nat Mater 8:543–557.
  • Nemmar A, Hoet PH, Vandervoort P, Dinsdale D, Nemery B, Hoylaerts MF. 2007. Enhanced peripheral thrombogenicity after lung inflammation is mediated by platelet-leukocyte activation: role of P-selectin. J Thromb Haemost 5:1217–1226.
  • Nie S, Xing Y, Kim GJ, Simons JW. 2007. Nanotechnology applications in cancer. Annu Rev Biomed Eng 9:257–288.
  • Nyman D. 1977. Collagen-induced platelet aggregation: evidence of several mechanisms for the induction of platelet release by collagen. Thromb Res 10:743–751.
  • Oberdorster G, Maynard A, Donaldson K, Castranova V, Fitzpatrick J, Ausman K, et al. 2005. Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy. Part Fibre Toxicol 2. 8.
  • Panzer S, Jilma P. 2011. Methods for testing platelet function for transfusion medicine. Vox Sang 101:1–9.
  • Panzer S, Rieger M, Vormittag R, Eichelberger B, Dunkler D, Pabinger I. 2007. Platelet function to estimate the bleeding risk in autoimmune thrombocytopenia. Eur J Clin Invest 37:814–819.
  • Patel DN, Bailey SR. 2007. Nanotechnology in cardiovascular medicine. Catheter Cardiovasc Interv 69:643–654.
  • Piret JP, Detriche S, Vigneron R, Vankoningsloo S, Rolin S, Mejia Mendoza JH, et al. 2010. Dispersion of multi-walled carbon nanotubes in biocompatible dispersants. J Nanopart Res 12:75–82.
  • Powers KW, Brown SC, Krishna VB, Wasdo SC, Moudgil BM, Roberts SM. 2006. Research strategies for safety evaluation of nanomaterials. Part VI. Characterization of nanoscale particles for toxicological evaluation. Toxicol Sci 90:296–303.
  • Radomski A, Jurasz P, Alonso-Escolano D, Drews M, Morandi M, Malinski T, et al. 2005. Nanoparticle-induced platelet aggregation and vascular thrombosis. Br J Pharmacol 146:882–893.
  • Ryan JJ, Bateman HR, Stover A, Gomez G, Norton SK, Zhao W, et al. 2007. Fullerene nanomaterials inhibit the allergic response. J Immunol 179:665–672.
  • Santos-Martinez MJ, Inkielewicz-Stepniak I, Medina C, Rahme K, D'Arcy DM, Fox D, et al. 2012. The use of quartz crystal microbalance with sissipation (QCM-D) for studying nanoparticle-induced platelet aggregation. Int J Nanomedicine 7:243–255.
  • Semberova J, De Paoli Lacerda SH, Simakova O, Holada K, Gelderman MP, Simak J. 2009. Carbon nanotubes activate blood platelets by inducing extracellular Ca2+ influx sensitive to calcium entry inhibitors. Nano Lett 9:3312–3317.
  • Semberova J, Holada K, Simakova O, Gelderman-Fuhrmann MP, Simak J. 2008. Carbon nanotubes activate platelets by facilitating extracellular Ca(2+) influx. Blood 112:365–366.
  • Shrivastava S, Bera T, Singh SK, Singh G, Ramachandrarao P, Dash D. 2009. Characterization of antiplatelet properties of silver nanoparticles. ACS Nano 3:1357–1364.
  • Simak J. 2009. Nanotoxicity in blood: effects of engineered nanomaterails on platelets. In: Sahu SC, Cascaciano DA, editors. Nanotoxicity: From in vivo and in vitro models to health risks. John Wiley & Sons. Chichester: pp. 191–225.
  • Singh SK, Singh MK, Nayak MK, Kumari S, Shrivastava S, Gracio JJA, et al. 2011. Thrombus inducing property of atomically thin graphene oxide sheets. ACS Nano 5(6):4987–4996.
  • Singh SK, Singh MK, Kulkarni PP, Sonkar VK, Gracio JJA, Dash D. 2012. Amine-modified graphene: Thrombo-protective safer alternative to graphene oxide for biomedical applications. ACS Nano 6(3):2731–2740.
  • Sitharaman B, Shi X, Walboomers XF, Liao H, Cuijpers V, Wilson LJ, et al. 2008. In vivo biocompatibility of ultra-short single-walled carbon nanotube/biodegradable polymer nanocomposites for bone tissue engineering. Bone 43:362–370.
  • Smyth SS, McEver RP, Weyrich AS, Morrell CN, Hoffman MR, Arepally GM, et al. 2009. Platelet functions beyond hemostasis. J Thromb Haemost 7:1759–1766.
  • Stevens KN, Knetsch ML, Sen A, Sambhy V, Koole LH. 2009. Disruption and activation of blood platelets in contact with an antimicrobial composite coating consisting of a pyridinium polymer and AgBr nanoparticles. ACS Appl Mater Interfaces 1:2049–2054.
  • Tirosh-Wagner T, Strauss T, Rubinshtein M, Tamarin I, Mishaly D, Paret G, et al. 2011. Point of care testing in children undergoing cardiopulmonary bypass. Pediatr Blood Cancer 56:794–798.
  • van Werkum JW, Bouman HJ, Breet NJ, ten Berg JM, Hackeng CM. 2010. The Cone-and-Plate(let) analyzer is not suitable to monitor clopidogrel therapy: a comparison with the flowcytometric VASP assay and optical aggregometry. Thromb Res 126:44–49.
  • Vankoningsloo S, Piret JP, Saout C, Noel F, Mejia J, Zouboulis CC, et al. 2010. Cytotoxicity of multi-walled carbon nanotubes in three skin cellular models: effects of sonication, dispersive agents and corneous layer of reconstructed epidermis. Nanotoxicology 4:84–97.
  • Zuo L, Wei W, Morris M, Wei J, Gorbounov M, Wei C. 2007. New technology and clinical applications of nanomedicine. Med Clin North Am 91:845–862.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.